VIDEO: Cell therapy shows consistency for treating corneal edema in three trials
Click Here to Manage Email Alerts
SEATTLE — In this Healio Video Perspective from the ARVO meeting, Michael H. Goldstein, MD, of Aurion Biotech discusses studies exploring the use of human corneal endothelial cells for corneal edema secondary to endothelial dysfunction.
“What we show is the remarkable consistency in the treatment effect across all three studies looking at key metrics for corneal health, in particular looking at anatomical endpoints such as corneal pachymetry and looking at functional endpoints such as vision,” Goldstein said.
Collapse
Goldstein MH, et al. Consistency of outcomes with injectable human corneal endothelial cell therapy across multiple clinical trials. Presented at: Association for Research in Vision and Ophthalmology meeting; May 5-9, 2024; Seattle.
Read more about
Click Here to Manage Email Alerts